Good afternoon :)
$
₹
CVS Health Corp

CVS Health Corp

CVS

NYSE
Asset Logo

CVS Health Corp

CVS

NYSE
$80.0112.46% (-11.39)
$
₹
$80.0112.46% (-11.39)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Healthcare Plans

Large Cap

With a market cap of $113.2B the stock is ranked 150

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

23.29
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

1.44
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$3.8
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

0.21
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

1.18%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

2.95%

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 27 analysts reports

Buy
25 analysts
Hold
2 analysts
Sell
0 analyst

Price Upside

+26.38%

Earnings Growth

+19.15%

Rev. Growth

+3.93%

See Detailed Forecast

Company Profile

Company Profile

CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail-order pharmacy, clinical services, disease management, medical spend management services, and pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, CMS, plans offered on public health insurance exchanges, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail-order pharmacy, clinical services, disease management, medical spend management services, and pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, CMS, plans offered on public health insurance exchanges, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
The Cigna Group
CI
The Cigna Group
P/E Ratio
12.20
12.20
1Y Return
11.63%
11.63%
Buy Reco %
70.83
70.83
Labcorp Holdings Inc.
LH
Labcorp Holdings Inc.
P/E Ratio
29.14
29.14
1Y Return
46.14%
46.14%
Buy Reco %
70.58
70.58
Quest Diagnostics Incorporated
DGX
Quest Diagnostics Incorporated
P/E Ratio
24.98
24.98
1Y Return
38.77%
38.77%
Buy Reco %
52.94
52.94
Guardant Health Inc
GH
Guardant Health Inc
P/E Ratio
—
—
1Y Return
78.31%
78.31%
Buy Reco %
96.15
96.15
BrightSpring Health Services, Inc. Common Stock
BTSG
BrightSpring Health Services, Inc. Common Stock
P/E Ratio
46.99
46.99
1Y Return
118.04%
118.04%
Buy Reco %
100.00
100.00
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Price Forecast

Price Forecast

Higher price growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The 12-month consensus target implies 26.38% growth, versus a trailing 3-year CAGR of 11.79%.

2026
Current$91.41Baseline
Analyst Target - 1 year
Target$115.52+26.38%

All values in $

202220232024202520262027$60.83$82.91$104.99Target+26.38%
2026
Current$91.41Baseline
Analyst Target - 1 year
Target$115.52+26.38%

All values in $

Revenue Forecast

Revenue Forecast

Lower revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 3.93% growth, versus a trailing 3-year CAGR of 7.63%.

2025
Current$402.06Baseline
Forecast for Dec 2026
High$427.32+6.28%
Average$417.87+3.93%
Low$414.06+2.98%

All values in $ Billion

202120222023202420252026292.11322.46357.77372.80402.06Low+2.98%Average+3.93%High+6.28%
2025
Current$402.06Baseline
Forecast for Dec 2026
High$427.32+6.28%
Average$417.87+3.93%
Low$414.06+2.98%

All values in $ Billion

Earnings Per Share Forecast

Earnings Per Share Forecast

Higher earnings growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 19.15% growth, versus a trailing 3-year CAGR of -8.32%.

2025
Current$6.75Baseline
Forecast for Dec 2026
High$8.15+20.79%
Average$8.04+19.15%
Low$7.94+17.63%

All values in $

2021202220232024202520268.418.768.745.426.75Low+17.63%Average+19.15%High+20.79%
2025
Current$6.75Baseline
Forecast for Dec 2026
High$8.15+20.79%
Average$8.04+19.15%
Low$7.94+17.63%

All values in $

Financials

Financials

Income

Balance Sheet

Cash Flow

102.8
-3.9
105.6
2.9
100.4
2.9
106
2.9
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue88.4391.2395.4297.7194.5898.91102.87105.69100.42106.09
Net Income1.111.770.081.641.771.02-3.972.942.942.99
Net Profit Margin1.25%1.94%0.09%1.68%1.88%1.03%-3.86%2.78%2.93%2.82%
See CostsAll values in $ Billion

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareHealthcare Plans

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
CVS Health Corp 23.291.440.21
The Cigna Group12.201.840.81
Labcorp Holdings Inc.29.143.261.57
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare CVS with any stock or ETF
Compare CVS with any stock or ETF
Comparing from
CVS
CI
LH
Loading...

Frequently asked questions

  1. CVS Health Corp (CVS) share price today is $80.01 as of November 5, 2026 at 2:29 AM IST. The stock touched a day high of $83.49 and a day low of $77.58.

  2. CVS Health Corp stock trades on NYSE under the ticker symbol CVS.

  3. CVS Health Corp's market capitalization is $113.2B as of November 5, 2026 at 2:29 AM IST.

  4. CVS Health Corp's price-to-earnings (P/E) ratio is 23.29 as of November 4, 2026.

  5. CVS Health Corp's price-to-book (P/B) ratio is 1.44 as of November 4, 2026.

  6. Yes, CVS Health Corp pays a dividend, with a current dividend yield of 2.95%.

  7. Yes, You can buy CVS Health Corp shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  8. Indian investors can buy CVS Health Corp shares in three steps: 1. Search CVS Health Corp on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  9. Since CVS Health Corp trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  10. Indian investors can start investing in CVS Health Corp (CVS) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.1249 shares at the current price of $80.01.

Loading...